Viracept is an effective drug has been manufactured by the leading pharmaceutical company, Agouron Pharmaceuticals, Inc. This drug is intended to prescribed to control human immunodeficiency virus (HIV). It has an active ingredient, Nelfinavir Mesylate, which is an antiretroviral protease inhibitor. It is made available in the form of a conventional tablet form. The available dosage is 250 mg.
Manufacturer: Agouron Pharmaceuticals, Inc
Active Ingredient: Nelfinavir Mesylate is the main active component of this antiviral medication. This component is an antiretroviral protease inhibitor indicated in the therapy and prevention of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. This drug can cause transient and usually asymptomatic elevations in serum aminotransferase levels. In HBV or HCV coinfected people, hepatic injury during antiretroviral therapy like nelfinavir may be a result of an exacerbation of the underlying chronic hepatitis B or C. This drug is an antiviral agent that binds to and inhibits human immunodeficiency virus (HIV) protease.
Indications: Given medication is indicated to control HIV infections. It helps to control HIV infection. It decreases the amount of HIV in the body so the immune system can work better. This process lowers the risk of getting HIV complications (like new infections, cancer. Viracept improves quality of life.
Action Mechanism: This mentioned protease inhibitor drug acts by interfering with an enzyme called protease. It is used by HIV-infected cells to make new viruses. It can also inhibit, or reduces the activity of this enzyme and causes HIV-infected cells to produce fewer viruses.
Dosages: This medication is available for oral administration ins a dosage as follows:
- 250 mg: This is an oral drug, should be taken with a meal 2 to 3 times a day or as mentioned in the prescription by the doctor
Note: This drug Viracept should not be used in people with moderate to severe liver disease unless prescribed by the doctor.